Advertisement
For patients with pulmonary arterial hypertension

Selexipag Linked to Reduced Risk of Death, Complications in PAH

0
Reduced risk of composite of death or pulmonary arterial hypertension-linked complications
In order to prevent denials

Specific, Consistent ICD-10 Coding Key to Timely Payments

0
Tips to prevent denials include checking EHR selection against documentation, being specific
A minority of patients discharged with chronic obstructive pulmonary disease receive pharmacologic treatment for tobacco use

Few Get Rx to Help Quit Smoking After COPD Hospitalization

0
Treatment not associated with cessation at six to 12 months; differences between medications
Uptravi (selexipag) has been approved by the U.S. Food and Drug Administration to treat adults with pulmonary arterial hypertension.

FDA Approves Uptravi for Pulmonary Arterial Hypertension

0
Drug found to limit worsening of the disease and reduce the need for hospitalization
For patients with acute myeloid leukemia

Daily Spirometry Can Give Early Warning of Pneumonia in AML

0
Patient-performed daily spirometry effective for early identification in patients with acute myeloid leukemia
Implementation of the Affordable Care Act has improved access to care and affordability of care for many adults

Affordable Care Act Has Improved Access to Care, Affordability

0
However, gaps in access to care and affordability still seen, especially for low-income adults
Pembrolizumab (Keytruda) may extend survival for patients with advanced non-small-cell lung cancer

Pembrolizumab Shows Promise in Metastatic NSCLC

0
In study, the immune-based therapy beat docetaxel with fewer side effects
Many patients with diagnosed obstructive sleep apnea are not being treated

Many Patients With Diagnosed OSA Not Receiving Treatment

0
Forty-two percent report adherence to PAP; 35 percent of untreated patients referred for management
For individual patients with poorly-controlled asthma

Nasal, Pharyngeal EPX Levels Linked to Sputum Eosinophilia

0
Strong correlation seen for eosinophil peroxidase levels in adults with poorly-controlled asthma
There's been a sharp rise in the number of industry-funded clinical trials and a significant decline in those financed by the U.S. government in recent years

Industry Outpacing NIH in Funding Research

0
Analysis finds studies paid for by private sector increasing, while U.S.-sponsored trials decline